Title |
The Expression Level of CB1 and CB2 Receptors Determines Their Efficacy at Inducing Apoptosis in Astrocytomas
|
---|---|
Published in |
PLOS ONE, January 2010
|
DOI | 10.1371/journal.pone.0008702 |
Pubmed ID | |
Authors |
Eiron Cudaback, William Marrs, Thomas Moeller, Nephi Stella |
Abstract |
Cannabinoids represent unique compounds for treating tumors, including astrocytomas. Whether CB(1) and CB(2) receptors mediate this therapeutic effect is unclear. |
X Demographics
The data shown below were collected from the profiles of 52 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 18 | 35% |
Austria | 1 | 2% |
Germany | 1 | 2% |
Argentina | 1 | 2% |
Canada | 1 | 2% |
United Kingdom | 1 | 2% |
Poland | 1 | 2% |
Chile | 1 | 2% |
Unknown | 27 | 52% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 51 | 98% |
Practitioners (doctors, other healthcare professionals) | 1 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 91 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Canada | 2 | 2% |
United States | 2 | 2% |
Jamaica | 1 | 1% |
Unknown | 86 | 95% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 18 | 20% |
Student > Master | 18 | 20% |
Researcher | 16 | 18% |
Student > Bachelor | 9 | 10% |
Other | 6 | 7% |
Other | 15 | 16% |
Unknown | 9 | 10% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 16 | 18% |
Agricultural and Biological Sciences | 16 | 18% |
Pharmacology, Toxicology and Pharmaceutical Science | 9 | 10% |
Medicine and Dentistry | 9 | 10% |
Neuroscience | 9 | 10% |
Other | 19 | 21% |
Unknown | 13 | 14% |